BRIEF published on 08/26/2025 at 07:35, 7 months 17 days ago Dermapharm Reports Stable Business in H1 2025 and Q2 EBITDA Growth Financial Results EBITDA Growth Revenue Stability Branded Pharmaceuticals Dermapharm Performance
PRESS RELEASE published on 08/26/2025 at 07:30, 7 months 17 days ago Dermapharm confirms stable business development in H1 2025 and records EBITDA growth in Q2 versus prior-year quarter Dermapharm confirms stable business development in H1 2025 with EBITDA growth in Q2. Full-year guidance for 2025 reiterated. Branded pharmaceuticals main growth driver Revenue Pharmaceuticals EBITDA Growth Dermapharm H1 2025
BRIEF published on 08/12/2025 at 07:35, 8 months ago Dermapharm Holding SE Continues Growth in Q2 2025 Revenue Forecast EBITDA Growth Branded Pharmaceuticals Dermapharm Q2 2025 Performance
PRESS RELEASE published on 08/12/2025 at 07:30, 8 months ago Dermapharm Holding SE remains on projected growth trajectory in Q2 2025 Dermapharm Holding SE reports Q2 2025 results in line with expectations. Confirms full-year guidance of EUR 1,160–1,200 million revenue and EUR 322–332 million EBITDA Pharmaceuticals EBITDA Growth Dermapharm Holding SE Full-year Guidance Q2 2025 Results
BRIEF published on 06/26/2025 at 17:48, 9 months 16 days ago Dermapharm Holding SE Approves EUR 0.90 Dividend Per Share Sustainability Dividend AGM Financial Outlook Dermapharm
PRESS RELEASE published on 06/26/2025 at 17:43, 9 months 16 days ago Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.90 per share Dermapharm Holding SE's Annual General Meeting approves divident distribution of EUR 0.90 per share for 2024, confirms 2025 outlook and ratifies Board actions Annual General Meeting Financial Year 2024 Dividend Distribution Dermapharm Holding SE EUR 0.90 Per Share
BRIEF published on 05/15/2025 at 07:35, 10 months 28 days ago Dermapharm Holding SE Meets Q1 2025 Expectations, Reinforces Full-Year Forecast Revenue Growth Full-year Guidance EBITDA Decline Branded Pharmaceuticals Dermapharm Q1 2025
PRESS RELEASE published on 05/15/2025 at 07:30, 10 months 28 days ago Dermapharm Holding SE performs in line with projections in Q1 2025, confirms full-year guidance Dermapharm Holding SE reports Q1 2025 results in line with projections, confirming full-year guidance. Revenue increases by 1.2% year-on-year to EUR 302.4 million Adjusted EBITDA Revenue Growth Dermapharm Holding SE Full-year Guidance Q1 2025 Results
BRIEF published on 03/28/2025 at 07:35, 1 year ago Dermapharm's 2024 Financial Performance Exceeds Expectations Revenue Increase EBITDA Growth Branded Pharmaceuticals Financial Results 2024 Dermapharm
PRESS RELEASE published on 03/28/2025 at 07:30, 1 year ago Successful financial year 2024: Dermapharm increases revenue and exceeds EBITDA guidance Dermapharm Holding SE reports successful financial year 2024 with increased revenue and exceeded EBITDA guidance. Full details in Annual Report Revenue Increase Financial Year 2024 EBITDA Guidance Annual Report Dermapharm Holding SE
Published on 04/11/2026 at 02:00, 1 day 20 hours ago Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Published on 04/11/2026 at 01:40, 1 day 21 hours ago Arctic Fox Announces Closing of Final Tranche Of Non-Brokered Private Placement
Published on 04/11/2026 at 00:30, 1 day 22 hours ago Trans Canada Gold Corp. Announces Proposed Warrant Extension
Published on 04/12/2026 at 21:25, 1 hour 18 minutes ago CGTN AMERICA & CCTV UN: UN Chinese Language Day Celebration with "Chinese Language Shining Civilizations" Event
Published on 04/12/2026 at 20:15, 2 hours 28 minutes ago CGTN AMERICA & CCTV UN: Commemoration of 55th Anniversary of Ping-Pong Diplomacy Held in Beijing
Published on 04/11/2026 at 16:45, 1 day 5 hours ago CGTN: One family: Xi Jinping stresses keeping future of cross-Strait ties in Chinese hands
Published on 04/11/2026 at 16:40, 1 day 6 hours ago VARON Delivers Advanced Portable Oxygen Concentrator to Meet Rising Demand in Europe
Published on 04/11/2026 at 16:30, 1 day 6 hours ago VARON Oxygen Concentrators Meet Rising Demand for Modern Oxygen Therapy in Germany
Published on 04/11/2026 at 16:29, 1 day 6 hours ago Passing of Madame Jacqueline Himsworth, Chairman of the Board of Directors of Manitou Group
Published on 04/10/2026 at 18:26, 2 days 4 hours ago EURAZEO ANNOUNCES THE SUCCESS OF ITS INAUGURAL 500 MILLION EURO BOND ISSUE
Published on 04/10/2026 at 18:00, 2 days 4 hours ago Declaration of voting rights at the end of March 2026
Published on 04/10/2026 at 17:45, 2 days 4 hours ago Imerys-10-04-2026-implementation of the share buyback program
